Category: St. Jude Medical
St. Jude Medical's attempts to distance its next-generation Durata defibrillator leads from the high-profile Riata recall may be making inroads with investors, analysts and physicians.
Medical device maker St. Jude Medical (NYSE:STJ) is feeling pretty confident about public perception of its Durata defibrillator leads, which came under scrutiny amid a high-profile recall of its older Riata leads.
A federal judge shoots down Biosense Webster's bid to keep a trio of former sales reps from working for cardiac rhythm management rival St. Jude Medical.
Boston Scientific presents interim findings for the Vessix renal denervation system, touting positive 6-month results in the 1st series of patients from the REDUCE-HTN clinical trial.
Boston Scientific (NYSE:BSX) unveiled a snapshot of its REDUCE-HTN clinical trial at EuroPCR this month, with interim data from the initial 41 patients treated with the company's Vessix renal denervation system.
MassDevice.com columnist Stephen Simpson on St. Jude Medical's stock activity, as shares have hit the mid-$40s in recent weeks.
By Stephen Simpson
St. Jude presents 1-year data supporting its EnligHTN device for patients with drug-resistant high blood pressure
St. Jude Medical (NYSE:STJ) released results for its EnligHTN renal denervation system trial, which effectively lowered blood pressure in patients after 1 year.
Data from EnliGHTN I was presented at the annual EuroPCR meeting in Paris, France.
Say hello to MassDevice +7, a bite-sized view of the top seven med-tech stories of the week. This latest feature of MassDevice.com's coverage highlights our seven biggest and most influential stories from the week's news to make sure you're up to date on the headlines that continue to shape the medical device industry.
Regulators in the European Union green-light St. Jude Medical's Ilumien Optis 3D vessel reconstruction technology to guide coronary stent placement.
St. Jude Medical (NYSE:STJ) today announced CE Mark approval of its Ilumien Optis PCI optimization system, designed to help physicians assess and treat patients with coronary artery disease.